2021
DOI: 10.1515/hsz-2020-0176
|View full text |Cite
|
Sign up to set email alerts
|

Myricetin protects pancreatic β-cells from human islet amyloid polypeptide (hIAPP) induced cytotoxicity and restores islet function

Abstract: The aberrant misfolding and self-assembly of human islet amyloid polypeptide (hIAPP)–a hormone that is co-secreted with insulin from pancreatic β-cells–into toxic oligomers, protofibrils and fibrils has been observed in type 2 diabetes mellitus (T2DM). The formation of these insoluble aggregates has been linked with the death and dysfunction of β-cells. Therefore, hIAPP aggregation has been identified as a therapeutic target for T2DM management. Several natural products are now being investigated for their pot… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
15
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 23 publications
(15 citation statements)
references
References 74 publications
0
15
0
Order By: Relevance
“…Despite these challenges, naturally-derived small molecules, specifically polyphenols, are commonly investigated for preventing Aβ40/IAPP self-aggregation ( Porat et al, 2006 ; Dhouafli et al, 2018 ). In this research, we selected the polyphenols, Caffeic acid ( Cheng et al, 2011 ; Chang et al, 2019 ), Myricetin ( Ono et al, 2003 , 2012 ; Shimmyo et al, 2008 ; DeToma et al, 2011 ; Zelus et al, 2012 ; Gargari et al, 2018 ; Dubey et al, 2021 ), Rosmarinic acid ( Ono et al, 2012 ; Sun et al, 2019 ), Curcumin ( Ono et al, 2004 ; Daval et al, 2010 ; Nedumpully-Govindan et al, 2016 ; Thapa et al, 2016 ), EGCG ( Bastianetto et al, 2006 ; Ehrnhoefer et al, 2008 ; Bieschke et al, 2010 ; Meng et al, 2010 ; Liu et al, 2011 ; Cao and Raleigh, 2012 ; Suzuki et al, 2012 ; Cheng et al, 2013 ; Hyung et al, 2013 ; Zhang et al, 2013 ; Wang Q. et al, 2014 ; Xu et al, 2016 ) and Silibinin ( Yin et al, 2011 ; Cheng B et al, 2012 ; Sciacca et al, 2017 ), as candidate inhibitors of Aβ40 and IAPP self-aggregation based on their known anti-aggregation activities in literature. Figure 5A demonstrates the chemical structures of the polyphenolic candidate inhibitors.…”
Section: Resultsmentioning
confidence: 99%
“…Despite these challenges, naturally-derived small molecules, specifically polyphenols, are commonly investigated for preventing Aβ40/IAPP self-aggregation ( Porat et al, 2006 ; Dhouafli et al, 2018 ). In this research, we selected the polyphenols, Caffeic acid ( Cheng et al, 2011 ; Chang et al, 2019 ), Myricetin ( Ono et al, 2003 , 2012 ; Shimmyo et al, 2008 ; DeToma et al, 2011 ; Zelus et al, 2012 ; Gargari et al, 2018 ; Dubey et al, 2021 ), Rosmarinic acid ( Ono et al, 2012 ; Sun et al, 2019 ), Curcumin ( Ono et al, 2004 ; Daval et al, 2010 ; Nedumpully-Govindan et al, 2016 ; Thapa et al, 2016 ), EGCG ( Bastianetto et al, 2006 ; Ehrnhoefer et al, 2008 ; Bieschke et al, 2010 ; Meng et al, 2010 ; Liu et al, 2011 ; Cao and Raleigh, 2012 ; Suzuki et al, 2012 ; Cheng et al, 2013 ; Hyung et al, 2013 ; Zhang et al, 2013 ; Wang Q. et al, 2014 ; Xu et al, 2016 ) and Silibinin ( Yin et al, 2011 ; Cheng B et al, 2012 ; Sciacca et al, 2017 ), as candidate inhibitors of Aβ40 and IAPP self-aggregation based on their known anti-aggregation activities in literature. Figure 5A demonstrates the chemical structures of the polyphenolic candidate inhibitors.…”
Section: Resultsmentioning
confidence: 99%
“…(Poly)phenols have been largely explored as a group of phytochemicals with potential to intervene in numerous diseases. Several molecules have been put forward as effective in suppressing IAPP aggregation ( 66 ), namely myricetin ( 67 ), resveratrol ( 24 ), and EGCG ( 20 ). Different (poly)phenols seem to act differently towards IAPP.…”
Section: Discussionmentioning
confidence: 99%
“…Several natural products and small molecules present abundantly in certain foods and plant materials have been substantially used in the past to manage T2DM [ 199 ]. Among these, natural products belonging to the flavonoid and curcuminoid families have been extensively assessed for their potential as hIAPP aggregation inhibitors ( Table S3 ) [ [200] , [201] , [202] , [203] , [204] , [205] , [206] , [207] , [208] , [209] , [210] , [211] , [212] , [213] , [214] , [215] , [216] , [217] , [218] , [219] , [220] , [221] , [222] , [223] , [224] , [225] , [226] , [227] , [228] , [229] , [230] , [231] ]. As mentioned earlier, most of these studies have been conducted using cell lines derived from pancreatic insulinoma of mouse or rat origin.…”
Section: Hiapp As a Drug Targetmentioning
confidence: 99%
“…It reduces oxidative stress and the associated DNA and membrane damages and restores the mitochondrial membrane potential. Myricetin supplementation also restores the function of pancreatic islets exposed to hIAPP [ 206 ].…”
Section: Hiapp As a Drug Targetmentioning
confidence: 99%